Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients
Yuqin Song(Peking University), Jun Zhu(Peking University), Jamie Hirata(Universidad San Carlos), Xin Wang(Shandong Provincial Hospital), Li Wang(Beijing Biocytogen (China)), Wenxin Liu(Jiujiang University), Liling Zhang(Union Hospital), Qingyuan Zhang(Third Affiliated Hospital of Harbin Medical University), Pengcheng He(Guangdong General Hospital), Qingqing Cai(Sun Yat-sen University), Rong Deng(IGM Biosciences (United States)), Yongping Song(Peking University), Lisa Musick
Cited by 2
Related Papers
Targeting the Wnt/β-catenin signaling pathway in cancer
|Journal of Hematology & Oncology|2020|1.4k
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
|Journal of Experimental & Clinical Cancer Research|2021|291
Accuracy of genomic selection in European maize elite breeding populations
|Theoretical and Applied Genetics|2011|287
Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory
|Nature Neuroscience|2015|282
Mutation of ZmDMP enhances haploid induction in maize
|Nature Plants|2019|276